About half of adults who still had probable long COVID a year after infection saw lasting improvement in their symptoms within three years, according to a study published Monday in Annals of Internal Medicine (opens in new tab).
Researchers led by Massachusetts General Hospital followed 1,019 adults in the NIH-funded RECOVER-Adult cohort. By two years after infection, 36.2% had sustained improvement; by three years, 50.1% did, and 26.9% had complete remission, according to the American College of Physicians, which publishes the journal.
Results varied widely by symptom pattern. About 60% of people whose illness was dominated by changes in smell or taste had improved by three years, compared with fewer than 19% of those whose symptoms affected multiple body systems, Bloomberg reported.
Participants counted as improved when their symptom score stayed below the threshold for likely long COVID at two consecutive visits.
Ziyad Al-Aly of the VA St. Louis Health Care System, who was not involved, said the scoring gives substantial weight to smell and taste loss and chronic cough. The multisystem group “is a different disease altogether,” he said. “This is the real long Covid that will endure, and these patients do not appear to show a robust trajectory of recovery.”
Nisreen Alwan of the University of Southampton noted that the symptom index has not been independently validated in other populations and that symptoms can fluctuate.
There is no approved treatment for long COVID. The authors said the findings point to the need for placebo-controlled trials of possible therapies.